A citation-based method for searching scientific literature

Antonio De Pascalis, Giuseppe Cianciolo, Irene Capelli, Giuliano Brunori, Gaetano La Manna. J Nephrol 2021
Times Cited: 7







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
57

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
42

Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
Radica Z Alicic, Michele T Rooney, Katherine R Tuttle. Clin J Am Soc Nephrol 2017
729
28

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
28

Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats.
Tomoko Yoshikawa, Takuya Kishi, Keisuke Shinohara, Ko Takesue, Risa Shibata, Noriyuki Sonoda, Toyoshi Inoguchi, Kenji Sunagawa, Hiroyuki Tsutsui, Yoshitaka Hirooka. Hypertens Res 2017
29
28

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
28

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
28

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
28

Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials.
Yumo Zhao, Lubin Xu, Dongli Tian, Peng Xia, Hua Zheng, Li Wang, Limeng Chen. Diabetes Obes Metab 2018
134
28

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.
William L Baker, Leo F Buckley, Michael S Kelly, John D Bucheit, Eric D Parod, Roy Brown, Salvatore Carbone, Antonio Abbate, Dave L Dixon. J Am Heart Assoc 2017
90
28

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
28

CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.
Ele Ferrannini, Michael Mark, Eric Mayoux. Diabetes Care 2016
564
28

Autophagy in diabetic nephropathy: a review.
Elias A T Koch, Rola Nakhoul, Farid Nakhoul, Nakhoul Nakhoul. Int Urol Nephrol 2020
14
14

Proteasomal and Autophagic Degradation Systems.
Ivan Dikic. Annu Rev Biochem 2017
488
14

Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems.
Viktor I Korolchuk, Fiona M Menzies, David C Rubinsztein. FEBS Lett 2010
401
14

A novel model to study renal myofibroblast formation in vitro.
C Grupp, I Troche, C Klass, M Köhler, G A Müller. Kidney Int 2001
22
14

Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Xiao-Ming Meng, Arthur C K Chung, Hui Y Lan. Clin Sci (Lond) 2013
248
14

Autophagy: machinery and regulation.
Zhangyuan Yin, Clarence Pascual, Daniel J Klionsky. Microb Cell 2016
322
14

Histopathology of diabetic nephropathy.
Paola Fioretto, Michael Mauer. Semin Nephrol 2007
263
14


Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.
Lorenzo Galluzzi, José Manuel Bravo-San Pedro, Beth Levine, Douglas R Green, Guido Kroemer. Nat Rev Drug Discov 2017
437
14

Autophagy in human health and disease.
Augustine M K Choi, Stefan W Ryter, Beth Levine. N Engl J Med 2013
14


MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy.
Yingying Zhang, Siqi Zhao, Depei Wu, Xingmei Liu, Mingjun Shi, Yuanyuan Wang, Fan Zhang, Jing Ding, Ying Xiao, Bing Guo. J Diabetes Res 2018
50
14

Extracellular matrix metabolism in diabetic nephropathy.
Roger M Mason, Nadia Abdel Wahab. J Am Soc Nephrol 2003
459
14

Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells.
Robert Koesters, Brigitte Kaissling, Michel Lehir, Nicolas Picard, Franziska Theilig, Rolf Gebhardt, Adam B Glick, Brunhilde Hähnel, Hiltraud Hosser, Hermann-Josef Gröne,[...]. Am J Pathol 2010
218
14

How to interpret LC3 immunoblotting.
Noboru Mizushima, Tamotsu Yoshimori. Autophagy 2007
14

TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
S Kanzler, A W Lohse, A Keil, J Henninger, H P Dienes, P Schirmacher, S Rose-John, K H zum Büschenfelde, M Blessing. Am J Physiol 1999
167
14

Autophagy in human health and disease.
Augustine M K Choi, Stefan W Ryter, Beth Levine. N Engl J Med 2013
370
14

Induction of cardiac fibrosis by transforming growth factor-beta(1).
P J Lijnen, V V Petrov, R H Fagard. Mol Genet Metab 2000
373
14

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
W A Border, S Okuda, L R Languino, M B Sporn, E Ruoslahti. Nature 1990
14


Regulation and role of autophagy in mammalian cells.
Alfred J Meijer, Patrice Codogno. Int J Biochem Cell Biol 2004
463
14

ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase.
Ryan C Russell, Ye Tian, Haixin Yuan, Hyun Woo Park, Yu-Yun Chang, Joungmok Kim, Haerin Kim, Thomas P Neufeld, Andrew Dillin, Kun-Liang Guan. Nat Cell Biol 2013
941
14

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.
Tao Jiang, Zheping Huang, Yifeng Lin, Zhigang Zhang, Deyu Fang, Donna D Zhang. Diabetes 2010
295
14

Autophagy promotes ferroptosis by degradation of ferritin.
Wen Hou, Yangchun Xie, Xinxin Song, Xiaofang Sun, Michael T Lotze, Herbert J Zeh, Rui Kang, Daolin Tang. Autophagy 2016
628
14

Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
Lingling Wu, Zhe Feng, Shaoyuan Cui, Kai Hou, Li Tang, Jianhui Zhou, Guangyan Cai, Yuansheng Xie, Quan Hong, Bo Fu,[...]. PLoS One 2013
73
14

Oxidative stress and autophagy: crucial modulators of kidney injury.
Angara Sureshbabu, Stefan W Ryter, Mary E Choi. Redox Biol 2015
179
14

The Role of Dietary Antioxidants on Oxidative Stress in Diabetic Nephropathy.
Francisco Gerardo Yanowsky-Escatell, Jorge Andrade-Sierra, Leonardo Pazarín-Villaseñor, Christian Santana-Arciniega, Eduardo De Jesús Torres-Vázquez, Jonathan Samuel Chávez-Iñiguez, Miguel Ángel Zambrano-Velarde, Francisco Martín Preciado-Figueroa. Iran J Kidney Dis 2020
9
14

Transforming Growth Factor-Beta1 in Diabetic Kidney Disease.
Lijun Zhao, Yutong Zou, Fang Liu. Front Cell Dev Biol 2020
34
14

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.
Robert L Chevalier, Michael S Forbes, Barbara A Thornhill. Kidney Int 2009
615
14

Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.
Kathryn A Moynihan, Andrew A Grimm, Marie M Plueger, Ernesto Bernal-Mizrachi, Eric Ford, Corentin Cras-Méneur, M Alan Permutt, Shin-Ichiro Imai. Cell Metab 2005
478
14

NQO1 Deficiency Leads Enhanced Autophagy in Cisplatin-Induced Acute Kidney Injury Through the AMPK/TSC2/mTOR Signaling Pathway.
Tae-Won Kim, Young-Jung Kim, Hyun-Tae Kim, Se-Ra Park, Mee-Young Lee, Yong-Deok Park, Chul-Ho Lee, Ju-Young Jung. Antioxid Redox Signal 2016
32
14

Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Yuanyuan Wang, Xiaohuan Zhang, Yanwen Mao, Luqun Liang, Lingling Liu, Wei Peng, Huiming Liu, Ying Xiao, Yingying Zhang, Fan Zhang,[...]. Exp Mol Pathol 2020
8
14

TGF-beta signaling in renal disease.
Erwin P Böttinger, Markus Bitzer. J Am Soc Nephrol 2002
605
14

Autophagy in diabetic nephropathy.
Yan Ding, Mary E Choi. J Endocrinol 2015
187
14

Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease.
Rafael Kramann, Claudia Goettsch, Janewit Wongboonsin, Hiroshi Iwata, Rebekka K Schneider, Christoph Kuppe, Nadine Kaesler, Monica Chang-Panesso, Flavia G Machado, Susannah Gratwohl,[...]. Cell Stem Cell 2016
182
14

Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase.
Isabelle Larosche, Philippe Lettéron, Alain Berson, Bernard Fromenty, Ting-Ting Huang, Richard Moreau, Dominique Pessayre, Abdellah Mansouri. J Pharmacol Exp Ther 2010
43
14


Autophagy: cellular and molecular mechanisms.
Danielle Glick, Sandra Barth, Kay F Macleod. J Pathol 2010
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.